We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC Finalizes Ranbaxy-Sun Pharma Merger Divestiture Order
FTC Finalizes Ranbaxy-Sun Pharma Merger Divestiture Order
The FTC signed off on a divestiture order allowing Sun Pharma’s imminent $4 billion purchase of fellow Indian generics maker Ranbaxy to go forward as long as the companies relinquish rights to the antibiotic minocycline.